王江霞, 王薇, 汪传高, 郭金森, 庞洪超. 90Y玻璃微球用于胰腺癌治疗时的器官剂量计算[J]. 中国辐射卫生, 2024, 33(3): 234-241.
WANG Jiangxia, WANG Wei, WANG Chuangao, GUO Jinsen, PANG Hongchao. Calculation of organ dose of 90Y TheraSphere in the treatment of pancreatic cancer. Chinese Journal of Radiological Health, 2024, 33(3): 234-241.
[1] Zheng RS, Zhang SW, Zeng HM, et al. Cancer incidence and mortality in China, 2016[J]. J Natl Cancer Center, 2022, 2(1): 1-9. [2] 高洁, 刘晓明, 周文华, 等. 90Y微球的研发现状与应用研究[J]. 同位素,2022,35(3):189-199. Gao J, Liu XM, Zhou WH, et al. Study on research and development status and application of 90Y microspheres[J]. J Isot, 2022, 35(3): 189-199. [3] 王斯妮, 贾中芝, 胡红杰, 等. 钇-90微球的特性、放射栓塞的操作技术及安全防护——钇-90微球放射栓塞系列回顾(一)[J]. 介入放射学杂志,2017,26(10):952-958. Wang SN, Jia ZZ, Hu HJ, et al. Characteristics of yttrium-90 microsphere, techniques and radiation safety of radioembolization procedure. A series review of radioembolization with yttrium-90 microspheres (part I)[J]. J Intervent Radiol, 2017, 26(10): 952-958. [4] 郑致远, 颜志平. 钇90放射性微球治疗肝脏恶性肿瘤的应用进展[J]. 复旦学报(医学版),2020,47(4):622-627. Zheng ZY, Yan ZP. Application progress of yttrium-90 radiation microspheres in treatment of liver malignancies[J]. Fudan Univ J Med Sci, 2020, 47(4): 622-627. [5] 赵开通, 白家瑞, 张国建. 90Y微球在肝细胞癌治疗中的临床应用价值及研究进展[J]. 国际放射医学核医学杂志,2023,47(7):435-438. Zhao KT, Bai JR, Zhang GJ. Clinical application value and research progress of 90Y microspheres in the treatment of hepatocellular cancinoma[J]. Int J Radiat Med Nucl Med, 2023, 47(7): 435-438. [6] Kayaleh R, Krzyston H, Rishi A, et al. Transarterial radioembolization treatment of pancreatic cancer patients with liver-dominant metastatic disease using yttrium-90 glass microspheres: a single-institution retrospective study[J]. J Vasc Interv Radiol, 2020, 31(7): 1060-1068. [7] Bolch WE, Jokisch D, Zankl M, et al. The ICRP computational framework for internal dose assessment for reference adults: specific absorbed fractions[J]. Ann ICRP, 2016, 45(2): 5-73. [8] 张震, 武祯, 梁婧. 基于蒙特卡罗模拟的探伤误照器官剂量计算[J]. 中国辐射卫生,2023,32(4):365-371,379. Zhang Z, Wu Z, Liang J. Monte Carlo simulation-based dose calculation for organs under accidental radiation exposure in flaw detection[J]. Chin J Radiol Health, 2023, 32(4): 365-371,379. [9] Menzel HG, Clement C, DeLuca P. ICRP Publication 110. Realistic reference phantoms: an ICRP/ICRU joint effort. A report of adult reference computational phantom[J]. Ann ICRP, 2009, 39(2): 1-164. [10] 汤晓斌, 陈达, 戴耀东, 等. 用CT值推导人体组织属性参数的方法及改进[J]. 南京航空航天大学学报,2006,38(3):373-377. Tang XB, Chen D, Dai YD, et al. Method for converting CT numbers into mass density and elemental weights of tissue and its improvement[J]. J Nanjing Univ Aeronaut Astronaut, 2006, 38(3): 373-377. DOI: 10.16356/j.1005-2615.2006.03.021. [11] Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network[J]. Magn Reson Imaging, 2012, 30(9): 1323-1341. [12] Allison J, Amako K, Apostolakis J, et al. Recent developments in GEANT4[J]. Nucl Instrum Methods Phys Res Sec A:Accel Spectrometers Detect Assoc Equip, 2016, 835: 186-225. [13] Zankl M, Schlattl H, Petoussi-Henss N, et al. Electron specific absorbed fractions for the adult male and female ICRP/ICRU reference computational phantoms[J]. Phys Med Biol, 2012, 57(14): 4501-4526. [14] Bhar M, Kadri O, Manai K. Assessment of self- and cross-absorbed SAF values for HDRK-man using GEANT4 code: internal photon and electron emitters[J]. Nucl Sci Tech, 2019, 30(10): 149. [15] Kesner AL, Carter LM, Ramos JCO, et al. MIRD pamphlet No. 28, Part 1: MIRDcalc—A software tool for medical internal radiation dosimetry[J]. J Nucl Med, 2023, 64(7): 1117-1124. [16] Sofocleous CT, Kamarinos NV. Tumor radiation-absorbed dose: the missing link in radioembolization[J]. Radiology, 2020, 296(3): 685-686. [17] 中国癌症研究基金会介入医学委员会, 国家放射与治疗临床医学研究中心, 国家介入医学创新联盟(筹). 晚期胰腺癌介入治疗临床操作指南(试行)(第六版)[J]. 临床肝胆病杂志,2022,38(6):1242-1251. Committee of Interventional Medicine, Cancer Foundation of China, National Clinical Research Center for Radiology and Therapy, National Innovation Alliance of Interventional Medicine (Prepared). Clinical practice guidelines for the interventional treatment of advanced pancreatic carcinoma (on trial) (6th edition)[J]. J Clin Hepatol, 2022, 38(6): 1242-1251.